Legal Representation
Attorney
Richard P. Sybert
USPTO Deadlines
Next Deadline
1644 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240702)
Due Date
July 02, 2030
Grace Period Ends
January 02, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 2, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 2, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 16, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 16, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 8, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 8, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 8, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 8, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 8, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 7, 2024 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jan 23, 2024 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Jan 8, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 8, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 8, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 8, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 8, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 4, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 4, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 4, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 21, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 21, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 21, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 21, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 13, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 25, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Cells and biological tissue, namely, blood, lymphocytes, T cells, stem cells, and T cell receptors for use in scientific, laboratory, and medical research; Cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation; lymphocytes in the nature of cells for scientific and research use; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for clinical trial, scientific, laboratory, and medical research; Biological reagents for scientific and medical research use; Biological preparations, namely, mononuclear cells, progenitor cells, and antibody preparations for use in medical clinical trials and medical research in the field of immunotherapy
First Use Anywhere:
Jan 25, 2022
First Use in Commerce:
Jan 25, 2022
Class 005
Pharmaceutical preparations for immunotherapy, namely, mononuclear cells, progenitor cells, and antibody preparations for medical purposes
First Use Anywhere:
Jan 25, 2022
First Use in Commerce:
Jan 25, 2022
Class 039
distributing human blood products for others, namely, transportation of blood products for others; Storage and retrieval of blood, peripheral blood mononuclear cells (PBMCs), tissue and stem cells for scientific, laboratory, and medical research
First Use Anywhere:
Jan 25, 2022
First Use in Commerce:
Jan 25, 2022
Class 040
bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies
First Use Anywhere:
Jan 25, 2022
First Use in Commerce:
Jan 25, 2022
Class 042
Medical research, namely research in the field of the blood process of patients' blood to isolate lymphocytes for the use in immunotherapy for therapeutic medical research
First Use Anywhere:
Jan 25, 2022
First Use in Commerce:
Jan 25, 2022
Class 044
Medical services, namely, processing of stem cells and white blood cells for use by others; stem cell and white blood cell storage, namely, stem cell and white blood cell bank services; collection and preservation of human blood, blood components, apheresis, peripheral blood mononuclear cells (PBMCs), plasma and bone marrow
First Use Anywhere:
Jan 25, 2022
First Use in Commerce:
Jan 25, 2022
Classification
International Classes
001
005
039
040
042
044